Does TALAZOPARIB Cause Metastases to bone? 14 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Metastases to bone have been filed in association with TALAZOPARIB (Talzenna). This represents 1.0% of all adverse event reports for TALAZOPARIB.
14
Reports of Metastases to bone with TALAZOPARIB
1.0%
of all TALAZOPARIB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Metastases to bone From TALAZOPARIB?
Of the 14 reports, 3 (21.4%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TALAZOPARIB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does TALAZOPARIB Cause?
Anaemia (219)
Neoplasm progression (169)
Death (142)
Off label use (78)
Thrombocytopenia (78)
Fatigue (77)
Platelet count decreased (68)
Haemoglobin decreased (65)
Febrile neutropenia (60)
Pancytopenia (60)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which TALAZOPARIB Alternatives Have Lower Metastases to bone Risk?
TALAZOPARIB vs TALC
TALAZOPARIB vs TALIGLUCERASE ALFA
TALAZOPARIB vs TALIMOGENE LAHERPAREPVEC
TALAZOPARIB vs TALQUETAMAB
TALAZOPARIB vs TALQUETAMAB-TGVS